Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Therapeutic effect of {beta}-adrenoceptor blockers using a mouse model of dilated cardiomyopathy with a troponin mutation.

Cardiovascular research - 1 Oct 2009

Zhan Dong-Yun, Morimoto Sachio, Du Cheng-Kun, Wang Yuan-Yuan, Lu Qun-Wei, Tanaka Atsushi, Ide Tomomi, Miwa Yoshikazu, Takahashi-Yanaga Fumi, Sasaguri Toshiyuki

Abstract excerpt

AIMS: Extensive clinical studies have demonstrated that beta-adrenoceptor blocking agents (beta-blockers) are beneficial in the treatment of chronic heart failure, which is due to various aetiologies, including idiopathic dilated cardiomyopathy (DCM) and ischaemic heart disease. However, little is known about the therapeutic efficacy of beta-blockers in the treatment of the inherited form of DCM, of which...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenergic beta-Antagonists
Share to Carbazoles

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cardiomyopathy, Dilated

Share to Electrocardiography

Share to Metoprolol

Share to Propanolamines

Share to Troponin T

Share to Ventricular Function, Left

Source

Identifiers

PMID: 19477965
DOI: 10.1093/cvr/cvp168

Genes

TNNT2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Therapeutic effect of {beta}-adrenoceptor blockers using a mouse model of dilated cardiomyopathy with a troponin mutation.PMID 19477965Read ↗

Cardiac disease and arrhythmogenesis: Mechanistic insights from mouse modelsSemantic proximity Read ↗

Models of dilated cardiomyopathy in the mouse and the hamster.Semantic proximity Read ↗

Dilated cardiomyopathy: concepts derived from gene deficient and transgenic animal models.Semantic proximity Read ↗

Genetic and phenotypic targeting of beta-adrenergic signaling in heart failure.Semantic proximity Read ↗

Multistep ion channel remodeling and lethal arrhythmia precede heart failure in a mouse model of inherited dilated cardiomyopathy.Semantic proximity Read ↗

Mitogen-activated protein kinase kinase 1/2 inhibition and angiotensin II converting inhibition in mice with cardiomyopathy caused by lamin A/C gene mutation.Semantic proximity Read ↗

Sex differences in response to miRNA‐34a therapy in mouse models of cardiac disease: identification of sex‐, disease‐ and treatment‐regulated miRNAsSemantic proximity Read ↗

Alpha2C-adrenoceptor polymorphism is associated with improved event-free survival in patients with dilated cardiomyopathy.Semantic proximity Read ↗

Roles of alpha1A- and alpha1B-adrenoceptors in heart: insights from studies of genetically modified mice.Semantic proximity Read ↗

Ranolazine Prevents Phenotype Development in a Mouse Model of Hypertrophic Cardiomyopathy.Semantic proximity Read ↗

Suppression of cyclooxygenase-2 predisposes to heart failure with preserved ejection fractionSemantic proximity Read ↗

Inhibition of miR-208b improves cardiac function in titin-based dilated cardiomyopathy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.